Position in GSK
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,527,325
-$229,083 QoQ
Shares Held
48,213
-3.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#222
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ledyard National Bank holds $47,693,201 across 10 Drug Manufacturers - General names. GSK ranks #7 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
45,244 | $11,490,617 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,938 | $9,244,033 | |
| 3 | AMGN |
Amgen Inc
|
25,394 | $9,195,674 | |
| 4 | LLY |
ELI LILLY & Co
|
4,276 | $5,128,762 | |
| 5 | PFE |
Pfizer Inc
|
181,271 | $4,365,005 | |
| 6 | ABBV |
AbbVie Inc.
|
17,080 | $4,298,010 | |
| 7 | GSK |
GSK plc
This page
|
48,213 | $2,527,325 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
17,142 | $987,721 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,527,325 | 48,213 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,756,408 | 49,944 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,417,867 | 49,304 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,125,888 | 49,256 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,910,361 | 49,749 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,724,084 | 44,504 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,303,557 | 38,544 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $992,606 | 24,281 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $753,406 | 19,569 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $573,000 | 13,366 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $250,859 | 6,769 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $245,376 | 6,769 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $241,247 | 6,769 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $240,841 | 6,769 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $248,053 | 7,059 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $207,746 | 7,059 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $376,861 | 8,827 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $393,100 | 9,201 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $404,461 | 9,351 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $361,684 | 9,651 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $365,207 | 9,351 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $327,329 | 9,351 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $341,913 | 9,473 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $353,409 | 9,573 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $384,985 | 9,623 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $357,614 | 9,623 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||